Journals By Industry - Analgesics

AMITYVILLE, N.Y. -- Hi-Tech Pharmacal Co., Inc. (NASDAQ:HITK), a specialty pharmaceuticals company, announced today that it has acquired marketing and distribution rights to a topical wound gel product from Glycobiosciences , Inc. The...

XenoPort to Receive $10 Million Milestone Payment TOKYO & SANTA CLARA, Calif. -- Astellas Pharma Inc. (Tokyo:4503) and XenoPort, Inc. (NASDAQ:XNPT) announced today that Regnite([R] ) (gabapentin enacarbil) has received marketing approval in...

DUBLIN -- Research and Markets (http://www.researchandmarkets.com/research/eb5d32/product_profiles) has announced the addition of the "Product Profiles: Moderate-To-Severe Acute Pain - Intensifying competition in breakthrough cancer pain market" report to their offering. Since the beginning of...

NEW YORK -- Forest Laboratories, Inc. (NYSE: FRX), an international pharmaceutical manufacturer and marketer, today announced that reported earnings per share were $1.04 in the third quarter of fiscal 2012. Reported earnings per...

DUBLIN -- Covidien plc (NYSE:COV), a leading global provider of healthcare products, today announced the appointment of Mark Trudeau as president of its Pharmaceuticals segment and a senior vice president of the Company,...

MARBLEHEAD, Mass. -- Medicinal Genomics, a pioneer in the genomics of medicinal plants, today announced the availability of Jane-Ome, an application designed for Apple's iPad tablet, which offers a science-based dissection of medical...

ARLINGTON, Va. -- A new study published this month in the Annals of Internal Medicine finds spinal manipulative therapy (SMT) and exercise more effective at relieving neck pain than pain medication. The research...

COLORADO SPRINGS, Colo. -- Cannabis Science, Inc. (OTCBB: CBIS.OB - News), a pioneering US biotech company developing pharmaceutical cannabis products, is happy to report an additional, apparently successful, self-medicated cannabis treatment for a...

LEXINGTON, Mass. & CAMBRIDGE, Mass. -- Cubist Pharmaceuticals, Inc. (NASDAQ: CBST) and Hydra Biosciences, Inc. today announced plans to begin a Phase 1 clinical trial for a small molecule antagonist of the human...

DUBLIN -- Research and Markets (http://www.researchandmarkets.com/research/fdebfc/postoperative_pai) has announced the addition of Global Markets Direct's new report, "Post-Operative Pain - Pipeline Review, H2 2011," to their offering. Global Markets Direct's "Post-Operative Pain - Pipeline...

BEDFORD, Mass. -- Anika Therapeutics, Inc. (Nasdaq: ANIK) a leader in products for tissue protection, healing and repair, based on hyaluronic acid ("HA") technology, today announced that Chief Financial Officer Kevin Quinlan will...

POSIDUR is a post-operative pain relief depot that utilizes the company's patented SABER technology to deliver bupivacaine and is designed to provide up to three days of pain relief after surgery. BESST was...

TARRYTOWN, N.Y. -- Regulatory News: EpiCept Corporation (Nasdaq OMX Stockholm Exchange and OTCQX: EPCT) today announced that it has engaged SunTrust Robinson Humphrey to assist in exploring strategic alternatives to maximize the commercial...

EXPAREL Expected to be Commercially Available in April 2012 PARSIPPANY, N.J. -- Pacira Pharmaceuticals, Inc. (NASDAQ: PCRX) today provided updated timing for its commercial launch of EXPAREL([R]) (bupivacaine liposome injectable suspension), a non-opioid...

Subsys is a sublingual spray formulation of the potent opioid fentanyl. With the treatment having been approved for breakthrough cancer pain, Insys Therapeutics intends to build up its sales force to market Subsys...

TARRYTOWN, N.Y. -- Regulatory News: EpiCept Corporation (Nasdaq OMX Stockholm Exchange and OTCQX: EPCT) today announced that Alan W. Dunton, M.D., has been appointed to the Company's Board of Directors and named Non-Executive...

TARRYTOWN, N.Y. -- Regulatory News: EpiCept Corporation (Nasdaq OMX Stockholm Exchange and OTCQX: EPCT) today announced that Jack Talley, President and CEO, will be presenting at two upcoming industry conferences. * The Biotech...

Talk Show Host Encourages Audiences to Start the New Year on the Right Nutritional Path by Featuring Supplements such as Melatonin, AcaiBerry, and "Easy-C ([R] )". CHATSWORTH, Calif. -- The "Year of the...

PARIS -- Regulatory News: BioAlliance Pharma SA (Paris:BIO)(Euronext Paris - BIO), a company dedicated to specialty and orphan oncology products, today announces the achievement of the reserved capital increase and the payment of...